logo
Disabled student's ‘agonisingly slow' journey across England using only public buses

Disabled student's ‘agonisingly slow' journey across England using only public buses

Independent28-05-2025
A disabled photography student has travelled more than 850 miles across England by public bus, spotlighting the everyday obstacles faced by disabled bus pass holders.
Dan Bowhay, 22, a final-year student at Arts University Bournemouth (AUB), embarked on the 10-day trip from Land's End in Cornwall to Marshall Meadows in Berwick-upon-Tweed, near the Scottish border.
The same journey would take just over nine hours by car.
Beginning on January 26 and concluding on February 6, Bowhay paused his travels over the weekend of February 1 and 2 to avoid reduced service frequencies.
He now plans to showcase a 10-hour documentary film to raise awareness about the "limited freedoms" experienced by disabled bus pass users.
'I am exploring what limited freedoms and independence this pass affords me,' Mr Bowhay told the PA news agency.
During each leg of his journey, Mr Bowhay travelled up to 10 hours a day, including time in transit on a bus and waiting for a connection.
His project, titled 'Between These Times', is a 'slow cinema' style film which emphasises long takes and observational shots.
'I've taken this genre and used it to kind of convey this journey I went on in this really slow format to show just how agonisingly slow it is to travel by bus, showing all these delays in that long, drawn out way,' said Mr Bowhay.
Mr Bowhay's bus pass is granted under the English National Concessionary Travel Scheme (ENCTS), which provides free travel by bus in England to those who are disabled.
The pass has its limitations as it is only valid on weekdays from 9.30am to 11pm, and is not available in Scotland or Wales, which causes issues for those who commute to work or live near borders, said Mr Bowhay.
He originally wanted to travel from Land's End to John o' Groats, but was limited to finishing at the border as his bus pass does not work in Scotland.
Aged four, Mr Bowhay became visually impaired when he developed cataracts in both eyes.
Mr Bowhay's left eye was removed and replaced with a prosthetic when he was four and he has limited vision in his right eye after the lens was replaced to treat his cataracts.
His condition means he struggles with his sight and depth perception, meaning he is unable to drive and is reliant on public transport for travel.
Mr Bowhay was inspired to create the film by the difficulties he had accessing public transport independently, where he grew up in Bishops Waltham, Hampshire.
'I attend a lot of hospital appointments at Southampton, and getting there independently is pretty impossible,' he said.
He said moving home after university does not feel 'viable' as the lack of public transport in the area limits his independence.
Of the 26 buses Mr Bowhay took during the 10-day journey, he said only three had audio and one had visual announcements to indicate the location of each stop, making travel more challenging for those with visual or hearing impediments.
'I had to spend a fair amount of time sort of looking out the window and trying to work out, actually, where I am, where I need to get off,' he said.
Problems Mr Bowhay faced during the trip included bus delays of up to 40 minutes a day, waiting times of up to a several hours for connections and difficulties with scanning his pass, meaning he often had to present his pass to a driver.
Mr Bowhay said he wants more investment to go into bus services and for the 'public attitude' to be more understanding of the challenges faced by disabled people using public transport.
The film will be shown at AUB's summer show from July 10-21 and Aberrations Collective's Show in Copeland Gallery, London, from July 31 to August 3.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lidl issues urgent ‘do not eat' warning over popular product amid allergy fear
Lidl issues urgent ‘do not eat' warning over popular product amid allergy fear

The Independent

time2 hours ago

  • The Independent

Lidl issues urgent ‘do not eat' warning over popular product amid allergy fear

A major UK supermarket has issued a product recall with a 'do not eat' warning for one if its popular meals. Lidl GB has told consumers who bought the Red Hen 4 Tempura Chicken Steaks 380g to check whether they are part of the affected batch. The product is being recalled because milk has not been boldened in the ingredients section - with the supermarket warning this could pose a health risk to people intolerant to milk. 'Lidl GB is recalling the above-mentioned product due to milk not being in bold within the back of pack ingredients,' the supermarket said in its product recall notice. 'This may be a possible health risk for anyone with an allergy to milk. 'If you have bought the above product and have an allergy to milk we advise you not to eat it. 'Customers are asked to return this product to the nearest store where a full refund will be given.' The Food Standards Agency (FSA) said the product 'contains milk making it a possible health risk for anyone with an allergy or intolerance to milk or milk constituents'. 'Lidl is recalling the above product from customers and has been advised to contact the relevant allergy support organisations, which will tell their members about the recall,' the FSA added. 'The company has also issued a point-of-sale notice to its customers. These notices explain to customers why the product is being recalled and tell them what to do if they have bought the product.' The recall only applies to the packs with the following 'best before' dates: 11/12/2026 16/12/2026 22/12/2026 30/12/2026 16/01/2027

Mystery surrounds abandoned UK village left to rot for 1,000 years that can only be entered through hidden cave tunnel
Mystery surrounds abandoned UK village left to rot for 1,000 years that can only be entered through hidden cave tunnel

The Sun

time2 hours ago

  • The Sun

Mystery surrounds abandoned UK village left to rot for 1,000 years that can only be entered through hidden cave tunnel

A MYSTERIOUS, 1,000 old village has become a popular tourist attraction and it's only accessible through a hidden tunnel. The path to the hidden settlement in the South West was uncovered by a group of diggers, hoping to get rich - who made a more important discovery. 3 3 The hidden site on the Penwitch Peninsula in Cornwall is accessible through a hidden cave known as a stone fogou. However, the miners stopped before reaching the village - disappointed when they didn't discover tin, which was valuable at the time. Eventually, after twenty years, Liberal politician WC Borlase decided to have the fogou fully excavated - but even he still managed to miss the village. Archeologists uncovered the perfectly preserved Iron Age village almost a century later. They found stone houses, circular drainage gullies and even potholes - which would have formed part of the timber round homes. The site was named Carn Euny, with 'carn' meaning a rocky place and 'Euny' being a celtic saint. The timber round houses at the site are believed to have been built between 500BC and 400BC. These would have been replaced by stone homes at a later date. The village would have kept cattle such as sheep and goats, while also practicing farming. Field boundaries suggest that the surrounding 40 acres would have been part of the community's farm. Pub With A 'Floating' Beer Garden By The Beach Despite living through the Iron Age and Roman occupation, the inhabitants vanished after the collapse of the Roman Empire in 400 AD. The site is now under the protection of English Heritage and is a popular destination for tourists. Cornwall is one of the most popular tourist destinations in the UK, with one beautiful Roman-style attraction being particularly popular. The coastal village of Porthcurno in Penzance is home to The Minack Theatre, which sees thousands of visitors each year. Created by architect Rowena Cade and her gardener Billy Rawlings in 1931, it was built by hand using tools and cement. She bought the land for just £100 after moving to the area in the years following the First World War. Since then, it has continued to attract history lovers from around the globe with fans describing it as 'magical' and 'spectacular'. 3

Streeting should ‘channel Thatcher' and introduce prostate screening
Streeting should ‘channel Thatcher' and introduce prostate screening

Telegraph

time2 hours ago

  • Telegraph

Streeting should ‘channel Thatcher' and introduce prostate screening

Wes Streeting should 'channel Margaret Thatcher ' and introduce screening for prostate cancer without delay, one of the world's leading experts has said. Prof Jonathan Waxman, the founder of the charity Prostate Cancer UK, says the Health Secretary should learn from Thatcher's decision to introduce routine mammograms for women, which he said had saved 3,000 lives a year since they were introduced in 1988. The Telegraph has launched a campaign calling for the introduction of targeted screening for prostate cancer so those at high risk are automatically offered tests. Prostate Cancer UK has submitted evidence in favour of the policy to the UK National Screening Committee (UKNSC), which is currently considering the matter, with a decision expected later this year. Writing for The Telegraph, Prof Waxman said: 'There are interesting parallels between the prostate cancer and breast cancer screening stories. 'In the 1970s, before breast cancer screening was introduced by Government dictat, the medical consensus was, and, you have guessed it, that early diagnosis through screening mammography would not save lives. 'Mrs T, regardless of the medical consensus, waved her handbag at the doctors, ignored the consensus, and launched a screening programme for breast cancer. And the result? Screening mammography, together with treatment advances, has led to a massive improvement in survival from breast cancer. 'Before screening, just 65 per cent of patients with breast cancer survived and now over 80 per cent are cured as a result of early detection and better treatment. 'And how does this improvement manifest in the real world? Around 3,000 fewer women die each year in the UK from breast cancer than before the screening programme was introduced.' The emeritus professor at Imperial College London said Prostate Cancer UK led a consortium of men's health charities to collectively inform the committee on the importance of targeted screening for those at highest risk. But he said the NHS should act now so that GPs do far more to help men at risk of prostate cancer. He urged the NHS to rewrite its guidance so that family doctors are told to proactively start conversations with men about the PSA blood tests which can detect the disease. Current guidance says that men can ask for a test, though some GPs rebuff them. For younger men, including those with a family history of disease, offering a test is down to the clinical judgment of GPs about. In both cases, the onus is on patients to seek help in the first place, with many men including those with family histories of prostate cancer unaware they are at heightened risk of the disease. Prof Waxman said the NHS should rewrite its advice so that GPs are told that they should bring up prostate cancer with all patients who might be at extra risk. He added that the guidelines should suggest that GPs start conversations with men from the age of 45 at highest risk, so those who wish to can obtain a PSA test. 'This puts the power of informed choice back in the hands of men who need it the most and is a crucial step on the path to early diagnosis,' he says. In the past, screening advisers have rejected the practice on the grounds that the tests are too unreliable, and could result in too many men undergoing needless procedures. However, in recent years the back-up diagnostics used to confirm the initial test findings have significantly improved. A Department of Health and Social Care spokesman said: 'This Government has been clear we would like to see screening in place, but the decision must be evidence-led. 'The UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research – GPs should consider risk factors and use clinical judgment when considering if patients need a prostate cancer test.' Prostate cancer is a lot more than a nuisance By Jonathan Waxman Sixty years ago, around 10,000 people in the UK were diagnosed annually with prostate cancer. Currently over 50,000 men are diagnosed each year and prostate cancer has the dreadful distinction of being the commonest cancer in men. In parallel, the number of prostate cancer deaths has increased from 3,300 to over 12,000 men annually. So, what to do? We can hope that the treatment of prostate cancer will improve and improve, and cures are found. Treatment is getting better. Thankfully, in 2025, well over 80 per cent of men with prostate cancer that has not spread beyond the prostate will be cured and the duration of survival for men with cancer that has spread has doubled compared with 25 years ago. These improvements have come because of modern medicine's marvellous miracles, developing from brilliant university research and big pharma's R & D. Prostate Cancer UK has invested over £120m in research over the years. But clearly despite the gloss of shiny medical breakthroughs, prostate cancer remains a fundamentally unpleasant problem, and a lot more than a nuisance. What can be done? Find it early, you say? Yes, that would seem logical. How do we do this? Well, if we want to find prostate cancer early then the obvious answer is to screen for prostate cancer. There is no UK screening programme for the early detection of prostate cancer, a cancer which is often without symptoms. The National Screening Committee is currently considering the role of screening for prostate cancer. Prostate Cancer UK has led a consortium of men's health charities to collectively inform the committee, which advises government, on the importance of targeted screening for those at highest risk. There are interesting parallels between the prostate cancer and breast cancer screening stories. In the 1970s, before breast cancer screening was introduced by Government dictat, the medical consensus was, and, you have guessed it, that early diagnosis through screening mammography would not save lives. Mrs T, regardless of the medical consensus, waved her handbag at the doctors, ignored the consensus, and launched a screening programme for breast cancer. And the result? Screening mammography together with treatment advances have led to a massive improvement in survival from breast cancer. Before screening, just 65 per cent of patients with breast cancer survived and now over 80 per cent are cured as a result of early detection and better treatment. And how does this improvement manifest in the real world? Around 3000 fewer women die in the UK from breast cancer each year than before the screening programme was introduced. To return to the debate on screening for prostate cancer. We are now at a critical inflection point in the history of prostate cancer screening. Last year, Prostate Cancer UK published research that showed prostate cancer diagnosis is safer and more accurate than ever before, and this in part is thanks to research the charity funded leading to MRI – Magnetic Resonance Imaging – being introduced into the diagnostic pathway. The National Screening Committee, under the iron baton of its excellent chair, is currently deliberating on the evidence for and against screening for prostate cancer and will issue a report this year. In heavily trailed remarks, Wes Streeting has indicated that he is in favour of screening but not for everyone, just for selective high risk groups of men. We at Prostate Cancer UK welcome this ministerial support, for it is also our view that there is a need for screening, and we believe the evidence is now there for targeted screening. We welcome his remarks at a time when we are about to launch TRANSFORM, a multi-centre screening trial using sophisticated technologies based on current diagnostic tools, an adaptive trial that is open to new screening tests. Prostate Cancer UK's trial invests £42m in a very long-term campaign to assess the survival benefits of modern screening methods. So, who are Mr Streeting's selective high risk groups of men at increased risk of prostate cancer? These are men with family histories of prostate cancer who constitute 1 to 5 per cent of all diagnosed patients, and black men, who have a one in four risk of prostate cancer, which is twice the risk of white men. What to do whilst we await the Screening Committee's conclusions? Currently GP guidelines concerning testing for prostate cancer are outdated. We urgently need these NHS guidelines updated to empower GPs to proactively start conversations about PSA testing with men from the age of 45 at highest risk. This puts the power of informed choice back in the hands of men who need it the most and is a crucial step on the path to early diagnosis. So, yes, prostate cancer is a bit of a nuisance, but let us see if we can do something about that nuisance. Prof Jonathan Waxman OBE is the founder and president of Prostate Cancer UK

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store